MoneyWorks4Me

The revenue zoomed 6.80% to Rs. 382.89 millions for the quarter ended September 2023 as compared to Rs. 358.52 millions during the corresponding quarter last year.Net profit stood at Rs. 73.22  millions  compared to Rs. 68.66 millions in the corresponding previous quarter,high by 6.64%.Operating Profit saw a handsome growth to 102.00 millions from 98.78 millions in the quarter ended September 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 382.89 358.52 6.80 674.64 669.84 0.72 1367.49 1239.80 10.30
Other Income 10.96 12.61 -13.08 21.33 24.04 -11.27 51.23 49.49 3.52
PBIDT 102.00 98.78 3.26 182.05 182.93 -0.48 354.90 322.04 10.20
Interest 0.69 0.94 -26.60 1.43 1.81 -20.99 3.67 4.35 -15.63
PBDT 101.31 97.84 3.55 180.62 181.12 -0.28 351.23 317.69 10.56
Depreciation 5.91 5.45 8.44 10.91 10.80 1.02 22.59 18.99 18.96
PBT 95.40 92.39 3.26 169.71 170.32 -0.36 328.64 298.70 10.02
TAX 22.18 23.73 -6.53 42.79 42.13 1.57 82.58 75.74 9.03
Deferred Tax -3.48 -1.27 174.02 -2.89 -2.10 37.62 -2.25 2.96 -176.01
PAT 73.22 68.66 6.64 126.92 128.19 -0.99 246.06 222.96 10.36
Equity 44.13 45.89 -3.84 44.13 45.89 -3.84 44.13 45.89 -3.84
PBIDTM(%) 26.64 27.55 -3.31 26.98 27.31 -1.19 25.95 25.98 -0.09
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..